401 related articles for article (PubMed ID: 28476123)
1. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
2. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.
Gilligan LC; Rahman HP; Hewitt AM; Sitch AJ; Gondal A; Arvaniti A; Taylor AE; Read ML; Morton DG; Foster PA
J Clin Endocrinol Metab; 2017 Dec; 102(12):4435-4447. PubMed ID: 28945888
[TBL] [Abstract][Full Text] [Related]
6. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
9. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
10. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
[TBL] [Abstract][Full Text] [Related]
11. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
Zhu G; Huang Y; Wu C; Wei D; Shi Y
DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
[TBL] [Abstract][Full Text] [Related]
15. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
[TBL] [Abstract][Full Text] [Related]
16. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
Vo DH; Hartig R; Weinert S; Haybaeck J; Nass N
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31540491
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.
Jiang X; Ye X; Ma J; Li W; Wu R; Jun L
Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628
[TBL] [Abstract][Full Text] [Related]
18. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
19. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract][Full Text] [Related]
20. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]